TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: […]

Preliminary revenue for the first three months of fiscal year 2024 is approximately equal to revenue for the first six months of fiscal year 2023 Committed to continually improve operations and cost structure, combined with a focus on product optimization and innovative commercial strategies that leverage the growth potential of the product portfolio, to expand margins, […]

The initial purchase order is expected to generate more than $7 million of net revenue and TRNR has sufficient inventory to fulfill the entire purchase order The Company confirms that it expects to generate net revenue of between $15 million and $20 million in 2024 AUSTIN, TX – (NewMediaWire) – February 26, 2024 – Interactive […]

Targeted enrollment of 54 patients completed ahead of schedule SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, with an emphasis on obesity and ocular indications, […]

$6.4 million of outstanding debt and liabilities have been eliminated over the past week; further strengthening the Company’s balance sheet NEW YORK, NY / ACCESSWIRE / February 23, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a unique holding company that combines the attributes of owning private, lower-middle market businesses with the liquidity and […]

Phoenix, Arizona—(Newsfile Corp. – February 23, 2024) – SinglePoint Inc. (CBOE: SING) or (the “Company”) a purpose-driven leader in the renewable energy sector, is pleased to announce a significant step to achieving operational profitability. As noted in our press release on February 21, 2024, the Company has acquired the remaining 19.9% interest in Boston Solar […]

NEW YORK, NY / ACCESSWIRE / February 23, 2024 / Not every investment is going to be a slam dunk, but 1847 Holdings LLC (NYSE American:EFSH) seems to have some exits under its belt that prove how enough success can overshadow any losses. The publicly traded diversified acquisition holding company hailing out of New York City acquires small businesses […]

MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that it will report its 2023 financial results after the market close on February 27, 2024. The Company will host a conference call at 5:00 p.m. ET […]

Management will provide insights on the remarkable results from the compassionate use study, the steps being undertaken to advance the Company’s lead asset, PRP, to a Phase 1b, First-in-Human (FIH), clinical study, and its future development pathway The call will be held on March 28, 2024, at 2:00pm, EST MELBOURNE, Australia, February 22, 2024–(BUSINESS WIRE)–Propanc […]